The U.S. Food and Drug Agency is not really a singular agency. In practice, it operates more like five or more “FDAs” — each ...

The new year ushered in a final slate of updates to the federal rules for how hospitals have to disclose their prices, and ...

The most read First Opinion essays of 2024 covered everything from the health insurance industry backlash to the right way to ...

The devices remain unreliable in darker skinned people. Researchers say more guidance, enforcement and even legal action may ...

Aletha Maybank, who became the American Medical Association’s first chief equity officer five and half years ago, is leaving ...

Top executives at Omada, Transcarent, Hinge Health and Maven Clinic reflect on the year that passed, and the year ahead for ...

Overall, 2025 is likely to feature significant discourse about the future of drug policy, addiction treatment, and harm ...

With Donald Trump taking office and Robert F. Kennedy Jr. poised to assume the nation’s top health role, it seems the agency is on the precipice of a big shake-up. Kennedy has floated loosening ...

Although bipartisan legislation to provide Medicare coverage for obesity treatments has circulated in Congress for more than ...

Sangamo, a gene therapy pioneer, loses a financial lifeline as Pfizer drops a gene therapy program for hemophilia.

The CDC said Thursday that the mutations, detected in a sample taken from a Louisiana patient, may help bind the virus to the ...

Former President Jimmy Carter, who died Sunday at age 100, gave visibility to devastating health problems that are often ...